What You Should Know about Japanese Encephalitis - References

References:

1. Collins MH, Metz SW. Progress and works in progress: update on flavivirus vaccine Development. Clin Ther. 2017 Jul 25. pii: S0149-2918(17)30768-3. doi: 10.1016/j.clinthera.2017.07.001. PMID: 28754189.
2. García LL, Padilla L, Castaño JC. Inhibitors compounds of the flavivirus replication process. Virol J. 2017 May 15;14(1):95. doi: 10.1186/s12985-017-0761-1. PMID: 28506240.
3. Basu A, Dutta K. Recent advances in Japanese encephalitis. F1000Res. 2017 Mar 13;6:259. doi: 10.12688/f1000research.9561.1. PMID: 28357054.
4. Vrati S, Bharati K. Chapter 110: Japanese encephalitis. In: Talwar GP, Hasnain SE, Sarin SK, editors. Textbook of Biochemistry, Biotechnology, Allied and Molecular Medicine. 4th ed. New Delhi: PHI Learning Private Limited; 2016. p. 1280-90.
5. Leibovitch EC, Jacobson S. Vaccinations for neuroinfectious disease: a global health priority. Neurotherapeutics. 2016 Jul;13(3):562-70. doi: 10.1007/s13311-016-0453-3. PMID: 27365085.
6. Chokephaibulkit K, Houillon G, Feroldi E, Bouckenooghe A. Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children. Expert Rev Vaccines. 2016;15(2):153-66. doi: 10.1586/14760584.2016.1123097. PMID: 26588242.
7. World Health Organization. Japanese encephalitis. Fact sheet No. 386. December 2015.
8. Pavli A, Maltezou HC. Travel-acquired Japanese encephalitis and vaccination considerations. J Infect Dev Ctries. 2015 Sep 27;9(9):917-24. doi: 10.3855/jidc.5108. PMID: 26409731.
9. Lord JS, Gurley ES, Pulliam JR. Rethinking Japanese encephalitis virus transmission: a framework for implicating host and vector species. PLoS Negl Trop Dis. 2015 Dec 10;9(12):e0004074. doi: 10.1371/journal.pntd.0004074. PMID: 26657648.
10. Erra EO, Kantele A. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis. Expert Rev Vaccines. 2015;14(9):1167-79. doi: 10.1586/14760584.2015.1061939. PMID: 26162529.
11. Ishikawa T, Konishi E. Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges. Expert Opin Ther Targets. 2015;19(10):1379-95. doi: 10.1517/14728222.2015.1065817. PMID: 26156208.
12. Wang H, Liang G. Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manag. 2015 Mar 19;11:435-48. doi: 10.2147/TCRM.S51168. PMID: 25848290.
13. Chen HL, Chang JK, Tang RB. Current recommendations for the Japanese encephalitis vaccine. J Chin Med Assoc. 2015 May;78(5):271-5. doi: 10.1016/j.jcma.2014.12.009. PMID: 25841620.
14. Firbas C, Jilma B. Product review on the JE vaccine IXIARO. Hum Vaccin Immunother. 2015;11(2):411-20. doi: 10.4161/21645515.2014.983412. PMID: 25621812.
15. Monath TP, Seligman SJ, Robertson JS, Guy B, Hayes EB, Condit RC, Excler JL, Mac LM, Carbery B, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment. Vaccine. 2015 Jan 1;33(1):62-72. doi: 10.1016/j.vaccine.2014.10.004. PMID: 25446819.
16. Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother. 2014;10(2):263-79. doi: 10.4161/hv.26902. PMID: 24161909.
17. Li X, Ma SJ, Liu X, Jiang LN, Zhou JH, Xiong YQ, Ding H, Chen Q. Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review. Hum Vaccin Immunother. 2014;10(12):3579-93. doi: 10.4161/21645515.2014.980197. PMID: 25668666.
18. Daep CA, Muñoz-Jordán JL, Eugenin EA. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. J Neurovirol. 2014 Dec;20(6):539-60. doi: 10.1007/s13365-014-0285-z. PMID: 25287260.
19. Ankur Nandan V, Nilesh K, Dibyaranjan B, Ashutosh T, Ravi A, Arvind A. Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: a rare presentation. Case Rep Infect Dis. 2013; 2013: 487659. doi: 10.1155/2013/487659. PMID: 23585973.
20. Ratnam I, Leder K, Black J, Biggs BA, Matchett E, Padiglione A, Woolley I, Panagiotidis T, Gherardin T, Luxemburger C, Torresi J. Low risk of Japanese encephalitis in short-term Australian travelers to Asia. J Travel Med. 2013; 20: 206-8. doi: 10.1111/jtm.12019. PMID: 23577868.

Author: Dr. Kaushik Bharati

Editor: Suchitra Chari

Technically Checked by: Lingaraj